Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders

By Castillo Jorge   Milani Cannon   Mendez-Allwood Daniel  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 491-500

Informa Healthcare

Access to resources Recommend Favorite

Anti-CD137 immunotherapy for autoimmune diseases?

By  

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

CD3-specific antibodies restore self-tolerance

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Preclinical Evaluation of a Monoclonal Antibody (3C6) Specific for Prostate-Specific Membrane Antigen

By  

Current Radiopharmaceuticals, Vol. 2, Iss. 1, 2009-01 ,pp. : 9-17

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Osteopontin in Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 4, 2010-09 ,pp. : 249-256

Bentham Science Publishers

Access to resources Recommend Favorite